Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Rapid Micro Biosystems reports 2021 results
Rapid Micro Biosystems reported fourth-quarter and full-year 2021 financial results, including full-year total revenue of $23.2 million and commercial revenue of $21.6 million.
2021
Rapid Micro Biosystems closes partial IPO over-allotment
Rapid Micro Biosystems said underwriters exercised their option in part to purchase 1,086,604 additional shares at $20 per share; the over-allotment exercise closed on August 4, 2021, generating $21.7 million in additional gross proceeds for the company.
2021
Rapid Micro Biosystems announces IPO pricing
Rapid Micro Biosystems announced pricing of its initial public offering of 7,920,000 Class A shares at $20 per share. The shares were expected to begin trading on Nasdaq on July 15, 2021, with the offering expected to close on July 19, subject to customary conditions.